Arcus Biosciences, Inc. - COM (RCUS)

Historical Portfolio Holders from Q1 2018 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
53.3M
Holdings value Q3 2024
$814M
Value change Q3 2024
+$20.4M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
183
Number of buys Q3 2024
85
Number of sells Q3 2024
-96
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 53.3M $814M +$20.4M $15.29 184
2024 Q2 52M $791M -$14.4M $15.23 192
2024 Q1 52.7M $996M -$650K $18.88 170
2023 Q4 52.8M $1.01B +$124K $19.10 181
2023 Q3 52.7M $947M -$32.3M $17.95 183
2023 Q2 54.7M $1.11B -$11.4M $20.31 178
2023 Q1 55.5M $1.01B +$17.4M $18.24 178
2022 Q4 53.8M $1.11B +$17.6M $20.68 200
2022 Q3 52.5M $1.37B -$110K $26.16 170
2022 Q2 52.4M $1.33B -$16M $25.34 164
2022 Q1 50.6M $1.6B -$43.8M $31.56 147
2021 Q4 50.8M $2.06B +$107M $40.47 139
2021 Q3 48.3M $1.68B +$59.9M $34.87 127
2021 Q2 45.1M $1.24B +$11.6M $27.46 128
2021 Q1 44.7M $1.25B +$7.9M $28.08 145
2020 Q4 44.6M $1.16B +$10.4M $25.96 144
2020 Q3 44.4M $761M +$17.6M $17.14 127
2020 Q2 41.8M $1.03B +$380M $24.74 139
2020 Q1 27M $375M -$448K $13.88 92
2019 Q4 23.6M $238M -$3.03M $10.10 74
2019 Q3 25.8M $235M -$672K $9.10 73
2019 Q2 26.4M $210M +$6.02M $7.95 76
2019 Q1 25.8M $322M -$12.7M $12.49 63
2018 Q4 26.9M $290M -$4.74M $10.77 66
2018 Q3 22.4M $313M +$951K $13.94 56
2018 Q2 22.4M $274M +$31.6M $12.24 61
2018 Q1 16.3M $251M +$251M $15.44 55